124731-65-3Relevant articles and documents
COMPOUNDS AS CD73 INHIBITORS
-
, (2022/05/06)
The present invention relates to compounds of formula I shown below: wherein R1 and R2 are each as defined in the application. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or conditions in which adenosine CD73 activity is implicated, such as, for example, cancer.